Personalized Med Dx Patent Reaffirmed By Machine-Or-Transformation Test
A federal appeals court reaffirmed the patentability of certain personalized medicine diagnostic claims, but it relied on a legal test that diagnostic and biotech firms have complained is overly restrictive.